Neprilysin 2 catalyses the degradation of natriuretic peptides despite sacubitrilat Inhibition

Abstract Neprilysin (NEP) cleaves active forms of A- and B-type natriuretic peptides (ANP and BNP) at multiple sites, reducing their compensatory effects in heart failure. Therapeutic inhibition of NEP by sacubitrilat may potentiate the beneficial effects of natriuretic peptides. Neprilysin 2 (NEP2)...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizaveta M. Selezneva, Evgeniya E. Feygina, Liudmila V. Ageeva, Fedor N. Rozov, Irina V. Kopylova, Evgeny P. Altshuler, Alexander G. Semenov
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-10166-z
Tags: Add Tag
No Tags, Be the first to tag this record!